Aleve’s “Rated #1” Claims Unsupported By Survey Design – NAD

This article was originally published in The Tan Sheet

09 Jul 2007
News

Robert W. Mitchell r.mitchell@elsevier.com

Executive Summary

Bayer Consumer Healthcare should modify product claims that imply Aleve is the number one pick among orthopedic surgeons for minor arthritis pain, the National Advertising Division of the Council of Better Business Bureaus recommends

Existing Subscriber? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Subjects
OTC Drugs

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

OTC Drugs

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS100673

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS100673

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Aleve’s “Rated #1” Claims Unsupported By Survey Design – NAD

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Aleve’s “Rated #1” Claims Unsupported By Survey Design – NAD

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert